◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...

HLS Therapeutics Inc.

Financial Statements (IFRS) · Amounts in CAD
5 10 All
Income Statement
Balance Sheet
Cash Flow
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Total Revenue 13.5M 14.2M 12.6M 15.5M 14.1M --
Operating Revenue 13.5M 14.2M 12.6M 15.5M 14.1M --
Cost Of Revenue 2.5M 2.5M 2.4M 2.7M 2.2M --
Gross Profit 11.0M 11.7M 10.2M 12.9M 11.8M --
Selling General And Administration 5.6M 5.6M 5.6M 6.2M 6.8M --
General And Administrative Expense 2.9M 2.5M 2.8M 2.7M 2.6M --
Depreciation And Amortization In Income Statement 5.5M 5.5M 5.4M 5.4M 5.5M --
Other Operating Expenses 1.3M 1.4M 1.4M 1.5M 1.4M --
Operating Expense 12.3M 12.4M 12.4M 13.2M 13.7M --
Operating Income -1.4M -778,000 -2.2M -300,000 -1.9M --
EBIT -1.5M -766,000 -2.4M -639,000 -2.5M --
Interest Expense 2.4M 1.7M 2.0M 2.3M 2.5M --
Interest Expense Non Operating 2.4M 1.7M 2.0M 2.3M 2.5M --
Interest Income 24,000 33,000 32,000 36,000 49,000 --
Interest Income Non Operating 24,000 33,000 32,000 36,000 49,000 --
Net Interest Income -2.4M -1.7M -2.0M -2.3M -2.4M --
Other Income Expense -140,000 -21,000 -282,000 -375,000 -607,000 --
Other Non Operating Income Expenses -534,000 -31,000 -296,000 641,000 -621,000 --
Special Income Charges 0.00 -- -- -- 0.00 0.00
Restructuring And Mergern Acquisition -- -- -- -- -- 0.00
Gain On Sale Of Security 394,000 10,000 14,000 492,000 14,000 --
Pretax Income -3.9M -2.5M -4.5M -2.9M -4.9M --
Tax Provision -17,000 242,000 -23,000 85,000 -59,000 --
Tax Effect Of Unusual Items 1,702 1,500 72.21 -152,400 168.47 --
Net Income From Continuing And Discontinued Operation -3.9M -2.7M -4.4M -3.0M -4.8M --
Net Income From Continuing Operation Net Minority Interest -3.9M -2.7M -4.4M -3.0M -4.8M --
Net Income Including Noncontrolling Interests -3.9M -2.7M -4.4M -3.0M -4.8M --
Net Income Common Stockholders -3.9M -2.7M -4.4M -3.0M -4.8M --
Net Income -3.9M -2.7M -4.4M -3.0M -4.8M --
EBITDA 4.0M 4.7M 2.9M 4.8M 3.1M --
Normalized EBITDA 3.6M 4.7M 2.9M 5.8M 3.0M --
Reconciled Depreciation 5.5M 5.5M 5.4M 5.4M 5.5M --
Basic EPS -0.12 -0.09 -0.14 -- -0.15 -0.18
Diluted EPS -0.12 -0.09 -0.14 -- -0.15 -0.18
Basic Average Shares 31.4M 30.5M 31.8M -- 31.8M 31.8M
Diluted Average Shares 31.4M 30.5M 31.8M -- 31.8M 31.8M
Total Unusual Items 394,000 10,000 14,000 -1.0M 14,000 --
Total Unusual Items Excluding Goodwill 394,000 10,000 14,000 -1.0M 14,000 --
Tax Rate For Calcs 0.00 0.15 0.01 0.15 0.01 --
Normalized Income -4.3M -2.7M -4.4M -2.2M -4.9M --
Depreciation Amortization Depletion Income Statement 5.5M 5.5M 5.4M 5.4M 5.5M --
Diluted NI Availto Com Stockholders -3.9M -2.7M -4.4M -3.0M -4.8M --
Gain On Sale Of Ppe 0.00 -- -- -- 0.00 --
Impairment Of Capital Assets -- -- -- -- -- 0.00
Net Income Continuous Operations -3.9M -2.7M -4.4M -3.0M -4.8M --
Net Non Operating Interest Income Expense -2.4M -1.7M -2.0M -2.3M -2.4M --
Other Gand A 2.1M 2.1M 2.1M 2.3M 2.1M --
Reconciled Cost Of Revenue 2.5M 2.5M 2.4M 2.7M 2.2M --
Salaries And Wages 785,000 465,000 651,000 423,000 511,000 --
Selling And Marketing Expense 2.7M 3.0M 2.8M 3.4M 4.2M --
Total Expenses 14.9M 14.9M 14.8M 15.8M 16.0M --
Total Operating Income As Reported -- -- -- -- -4.9M --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Cash And Cash Equivalents 10.8M 12.2M 17.7M 17.5M 17.5M --
Cash Cash Equivalents And Short Term Investments 10.8M 12.2M 17.7M 17.5M 17.5M --
Cash Financial 10.8M 12.2M 17.7M 17.5M 17.5M --
Accounts Receivable 7.7M 8.5M 7.0M 6.7M 9.2M --
Receivables 8.2M 9.0M 7.8M 7.5M 10.6M --
Inventory 7.1M 6.8M 7.5M 9.1M 7.7M --
Prepaid Assets -- -- -- 1.4M -- --
Other Current Assets 1.4M 2.0M 1.0M -- 1.8M 2.3M
Current Assets 27.5M 30.0M 34.1M 35.4M 37.6M --
Gross PPE -- -- -- 3.2M -- --
Accumulated Depreciation -- -- -- -2.2M -- --
Net PPE 1.3M 1.0M 972,000 997,000 897,000 --
Goodwill And Other Intangible Assets 109.7M 116.0M 117.2M 122.1M 132.0M --
Other Intangible Assets 109.7M 116.0M -- 122.1M -- --
Other Non Current Assets 545,000 556,000 530,000 528,000 607,000 --
Total Non Current Assets 112.7M 119.0M 119.9M 124.5M 134.2M --
Total Assets 140.2M 149.1M 153.9M 159.9M 171.7M --
Current Debt 4.3M 5.8M 5.3M 4.8M 4.3M --
Current Debt And Capital Lease Obligation 4.8M 6.1M 5.7M 5.3M 4.8M --
Accounts Payable 10.6M 8.3M 8.7M 8.7M 13.5M --
Payables 11.0M 8.8M 9.1M 8.9M 13.6M --
Payables And Accrued Expenses 11.0M 8.8M 9.1M 8.9M 13.6M --
Other Current Liabilities -- 878,000 512,000 33,000 -- 1.5M
Current Liabilities 23.5M 27.6M 23.8M 22.5M 24.1M --
Long Term Debt 48.8M 49.0M 57.6M 60.7M 63.4M --
Long Term Debt And Capital Lease Obligation 49.3M 49.4M 58.1M 61.2M 63.8M --
Long Term Capital Lease Obligation 502,000 457,000 417,000 426,000 376,000 --
Other Non Current Liabilities 1.8M 1.4M 1.1M 778,000 735,000 --
Total Non Current Liabilities Net Minority Interest 55.0M 54.9M 63.3M 66.0M 68.3M --
Total Liabilities Net Minority Interest 78.5M 82.5M 87.1M 88.6M 92.4M --
Common Stock 256.4M 258.1M 260.1M 260.6M 260.6M --
Capital Stock 256.4M 258.1M 260.1M 260.6M 260.6M --
Additional Paid In Capital 15.9M 14.8M 14.9M 15.1M 14.9M --
Retained Earnings -202.8M -199.8M -198.3M -194.2M -191.2M --
Gains Losses Not Affecting Retained Earnings -7.7M -6.5M -9.9M -10.2M -5.0M --
Other Equity Adjustments -7.7M -6.5M -9.9M -10.2M -5.0M --
Common Stock Equity 61.7M 66.6M 66.8M 71.3M 79.3M --
Stockholders Equity 61.7M 66.6M 66.8M 71.3M 79.3M --
Total Equity Gross Minority Interest 61.7M 66.6M 66.8M 71.3M 79.3M --
Total Capitalization 110.6M 115.5M 124.4M 132.1M 142.8M --
Net Tangible Assets -47.9M -49.5M -50.4M -50.8M -52.7M --
Tangible Book Value -47.9M -49.5M -50.4M -50.8M -52.7M --
Working Capital 4.0M 2.4M 10.2M 12.9M 13.5M --
Invested Capital 114.8M 121.3M 129.7M 136.9M 147.1M --
Total Debt 54.1M 55.6M 63.7M 66.5M 68.6M --
Net Debt 42.3M 42.6M 45.2M 48.1M 50.2M --
Share Issued 31.3M 31.5M 31.7M 31.8M 31.8M --
Ordinary Shares Number 31.3M 31.5M 31.7M 31.8M 31.8M --
Capital Lease Obligations 999,000 853,000 836,000 882,000 842,000 --
Current Capital Lease Obligation 497,000 396,000 419,000 456,000 466,000 --
Current Provisions 7.7M 11.8M 8.6M 8.4M 5.6M --
Hedging Assets Current -- -- -- 0.00 -- --
Income Tax Payable 390,000 411,000 394,000 152,000 149,000 --
Machinery Furniture Equipment -- -- -- 1.2M -- --
Non Current Deferred Assets 1.2M 1.4M 1.2M 857,000 619,000 --
Non Current Deferred Liabilities 3.9M 4.1M 4.1M 4.1M 3.8M --
Non Current Deferred Taxes Assets 1.2M 1.4M 1.2M 857,000 619,000 --
Non Current Deferred Taxes Liabilities 3.9M 4.1M 4.1M 4.1M 3.8M --
Other Current Borrowings 4.3M 5.8M 5.3M 4.8M 4.3M --
Other Properties -- -- -- 2.0M -- --
Other Receivables 467,000 497,000 752,000 732,000 1.2M --
Taxes Receivable 38,000 80,000 71,000 71,000 98,000 --
Total Tax Payable 390,000 411,000 394,000 152,000 149,000 --
Line Item Q3 2025Sep 30, 2025 Q2 2025Jun 30, 2025 Q1 2025Mar 31, 2025 Q4 2024Dec 31, 2024 Q3 2024Sep 30, 2024 Q2 2024Jun 30, 2024
Operating Cash Flow 2.5M 4.6M 3.5M 3.2M 1.5M --
Cash Flow From Continuing Operating Activities 2.5M 4.6M 3.5M 3.2M 1.5M --
Depreciation And Amortization 5.5M 5.5M 5.4M 5.4M 5.5M --
Depreciation Amortization Depletion 5.5M 5.5M 5.4M 5.4M 5.5M --
Stock Based Compensation 785,000 465,000 651,000 423,000 511,000 --
Deferred Tax -62,000 -189,000 -289,000 59,000 -47,000 --
Deferred Income Tax -62,000 -189,000 -289,000 59,000 -47,000 --
Change In Working Capital -739,000 1.3M 1.9M -5,000 2,000 --
Changes In Account Receivables 664,000 -905,000 -243,000 2.4M -1.2M --
Change In Receivables 706,000 -914,000 -243,000 2.4M -1.2M --
Change In Inventory -405,000 1.0M 1.6M -1.8M 1.2M --
Change In Payables And Accrued Expense 2.5M -1.2M 72,000 -3.7M 842,000 --
Change In Payable 2.5M -1.2M 72,000 -3.7M 842,000 --
Change In Other Working Capital -4.1M 3.3M 194,000 2.7M -1.4M --
Change In Other Current Assets 584,000 -901,000 318,000 333,000 588,000 --
Other Non Cash Items 1.3M 302,000 308,000 314,000 353,000 --
Capital Expenditure -279,000 -1.1M -21,000 -13,000 -- --
Purchase Of PPE -64,000 -87,000 -21,000 -13,000 0.00 --
Net PPE Purchase And Sale -64,000 -87,000 -21,000 -13,000 0.00 --
Purchase Of Business -- -- -- 0.00 -- --
Investing Cash Flow -279,000 -1.1M -21,000 -13,000 -1.5M --
Cash Flow From Continuing Investing Activities -279,000 -1.1M -21,000 -13,000 -1.5M --
Repayment Of Debt -58.7M -8.6M -3.1M -2.7M -15.1M --
Net Issuance Payments Of Debt -1.4M -8.6M -3.1M -2.7M -15.1M --
Repurchase Of Capital Stock -783,000 -833,000 -176,000 0.00 0.00 --
Net Common Stock Issuance -783,000 -833,000 -176,000 0.00 0.00 --
Common Stock Dividend Paid -- -- -- 0.00 0.00 0.00
Common Stock Payments -783,000 -833,000 -176,000 0.00 0.00 --
Financing Cash Flow -3.4M -9.5M -3.3M -2.7M -15.1M --
Cash Flow From Continuing Financing Activities -3.4M -9.5M -3.3M -2.7M -15.1M --
Effect Of Exchange Rate Changes -128,000 367,000 35,000 -622,000 120,000 --
Changes In Cash -1.2M -5.9M 243,000 538,000 -15.1M --
Beginning Cash Position 12.2M 17.7M 17.5M 17.5M 32.5M --
End Cash Position 10.8M 12.2M 17.7M 17.5M 17.5M --
Free Cash Flow 2.2M 3.5M 3.5M 3.2M 1.5M --
Asset Impairment Charge -- -- -- 0.00 0.00 --
Cash Dividends Paid -- -- -- 0.00 0.00 0.00
Change In Account Payable 2.5M -1.2M -170,000 -3.7M 851,000 --
Change In Income Tax Payable -21,000 17,000 242,000 3,000 -9,000 --
Change In Tax Payable -21,000 17,000 242,000 3,000 -9,000 --
Gain Loss On Sale Of PPE 0.00 -- -- 0.00 0.00 --
Long Term Debt Payments -58.7M -8.6M -3.1M -2.7M -15.1M --
Net Business Purchase And Sale -- -- -- 0.00 -- --
Net Income From Continuing Operations -3.9M -2.7M -4.4M -3.0M -4.8M --
Net Intangibles Purchase And Sale -215,000 -- -- 0.00 0.00 --
Net Long Term Debt Issuance -1.4M -8.6M -3.1M -2.7M -15.1M --
Net Other Financing Charges -- -- -- 0.00 0.00 -658,000
Operating Gains Losses -- -- -- 0.00 0.00 --
Proceeds From Stock Option Exercised -- -- -- 0.00 0.00 0.00
Purchase Of Intangibles -215,000 -- -- 0.00 0.00 --
Sale Of Intangibles 0.00 -- -- 0.00 0.00 --
Unrealized Gain Loss On Investment Securities 0.00 0.00 0.00 3,000 18,000 --
NEWS
Loading news...
TRENDING
Loading...